Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

NCT03367260 ·Status: COMPLETED

Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases

NCT01048814 ·Status: COMPLETED

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

NCT00043472 ·Status: COMPLETED

The INFLUENCE of Cytoreduction on PRO in EOC

NCT03268876 ·Status: ACTIVE_NOT_RECRUITING

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

NCT03296826 ·Status: RECRUITING

Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer

NCT00003794 ·Status: TERMINATED

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

NCT04752865 ·Status: UNKNOWN

Prognostic and Predictive Biomarkers in Ovarian Cancers

NCT03010124 ·Status: RECRUITING ·Phase: NA

Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance

NCT05704621 ·Status: RECRUITING ·Phase: PHASE2

Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer

NCT06775470 ·Status: RECRUITING

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

NCT05200260 ·Status: RECRUITING ·Phase: PHASE2

Spectroscopy in Ovarian Cancer

NCT04817449 ·Status: COMPLETED

New Biomarkers Evaluating Ovarian Cancer

NCT01466049 ·Status: COMPLETED

Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer

NCT05371301 ·Status: UNKNOWN ·Phase: PHASE3

Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer

NCT04300699 ·Status: UNKNOWN ·Phase: NA

Optimising Cardiovascular Health in Endometrial Cancer Survivors

NCT05216913 ·Status: UNKNOWN

Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype

NCT05574673 ·Status: RECRUITING

Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer

NCT06907771 ·Status: RECRUITING

A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index

NCT01823731 ·Status: UNKNOWN

Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer

NCT07031908 ·Status: NOT_YET_RECRUITING

Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer

NCT01175967 ·Status: TERMINATED

Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy

NCT02686463 ·Status: UNKNOWN ·Phase: NA

Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT00075712 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00897806 ·Status: TERMINATED

Quality-of-Life Assessment in Patients With Ovarian Cancer

NCT00003772 ·Status: COMPLETED